BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 20223936)

  • 1. Stromal regulation of vessel stability by MMP14 and TGFbeta.
    Sounni NE; Dehne K; van Kempen L; Egeblad M; Affara NI; Cuevas I; Wiesen J; Junankar S; Korets L; Lee J; Shen J; Morrison CJ; Overall CM; Krane SM; Werb Z; Boudreau N; Coussens LM
    Dis Model Mech; 2010; 3(5-6):317-32. PubMed ID: 20223936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of TGFβ type I receptor activity facilitates liver regeneration upon acute CCl4 intoxication in mice.
    Karkampouna S; Goumans MJ; Ten Dijke P; Dooley S; Kruithof-de Julio M
    Arch Toxicol; 2016 Feb; 90(2):347-57. PubMed ID: 25566828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PGE2 induces angiogenesis via MT1-MMP-mediated activation of the TGFbeta/Alk5 signaling pathway.
    Alfranca A; López-Oliva JM; Genís L; López-Maderuelo D; Mirones I; Salvado D; Quesada AJ; Arroyo AG; Redondo JM
    Blood; 2008 Aug; 112(4):1120-8. PubMed ID: 18541723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tgf-beta type I receptor (Alk5) kinase inhibitors in oncology.
    Ling LE; Lee WC
    Curr Pharm Biotechnol; 2011 Dec; 12(12):2190-202. PubMed ID: 21619541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compensatory signalling induced in the yolk sac vasculature by deletion of TGFbeta receptors in mice.
    Carvalho RL; Itoh F; Goumans MJ; Lebrin F; Kato M; Takahashi S; Ema M; Itoh S; van Rooijen M; Bertolino P; Ten Dijke P; Mummery CL
    J Cell Sci; 2007 Dec; 120(Pt 24):4269-77. PubMed ID: 18029401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of ΔNp63α via a novel TGFβ/ALK5 signaling mechanism mediates the anti-clonogenic effects of TGFβ.
    Cherukuri P; DeCastro AJ; Balboni AL; Downey SL; Liu JY; Hutchinson JA; DiRenzo J
    PLoS One; 2012; 7(11):e50066. PubMed ID: 23166821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling.
    Goumans MJ; Valdimarsdottir G; Itoh S; Lebrin F; Larsson J; Mummery C; Karlsson S; ten Dijke P
    Mol Cell; 2003 Oct; 12(4):817-28. PubMed ID: 14580334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a TGFbeta type I receptor inhibitor in mouse skin carcinogenesis reveals a dual role for TGFbeta signaling in tumor promotion and progression.
    Mordasky Markell L; Pérez-Lorenzo R; Masiuk KE; Kennett MJ; Glick AB
    Carcinogenesis; 2010 Dec; 31(12):2127-35. PubMed ID: 20852150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGFβ1 inhibition increases the radiosensitivity of breast cancer cells in vitro and promotes tumor control by radiation in vivo.
    Bouquet F; Pal A; Pilones KA; Demaria S; Hann B; Akhurst RJ; Babb JS; Lonning SM; DeWyngaert JK; Formenti SC; Barcellos-Hoff MH
    Clin Cancer Res; 2011 Nov; 17(21):6754-65. PubMed ID: 22028490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
    Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
    Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma.
    Sonnylal S; Denton CP; Zheng B; Keene DR; He R; Adams HP; Vanpelt CS; Geng YJ; Deng JM; Behringer RR; de Crombrugghe B
    Arthritis Rheum; 2007 Jan; 56(1):334-44. PubMed ID: 17195237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGFbeta-stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro-migratory TGFbeta switch.
    Liu IM; Schilling SH; Knouse KA; Choy L; Derynck R; Wang XF
    EMBO J; 2009 Jan; 28(2):88-98. PubMed ID: 19096363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-independent transforming growth factor-β type I receptor signalling mediates type I collagen-induced epithelial-mesenchymal transition.
    DeMaio L; Buckley ST; Krishnaveni MS; Flodby P; Dubourd M; Banfalvi A; Xing Y; Ehrhardt C; Minoo P; Zhou B; Crandall ED; Borok Z
    J Pathol; 2012 Mar; 226(4):633-44. PubMed ID: 21984393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement of TGFbeta signaling for SMO-mediated carcinogenesis.
    Fan Q; He M; Sheng T; Zhang X; Sinha M; Luxon B; Zhao X; Xie J
    J Biol Chem; 2010 Nov; 285(47):36570-6. PubMed ID: 20858897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy.
    Ager EI; Kozin SV; Kirkpatrick ND; Seano G; Kodack DP; Askoxylakis V; Huang Y; Goel S; Snuderl M; Muzikansky A; Finkelstein DM; Dransfield DT; Devy L; Boucher Y; Fukumura D; Jain RK
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25710962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes-relevant regulation of cultured blood outgrowth endothelial cells.
    Wang S; Hirschberg R
    Microvasc Res; 2009 Sep; 78(2):174-9. PubMed ID: 19539633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis.
    Oh SP; Seki T; Goss KA; Imamura T; Yi Y; Donahoe PK; Li L; Miyazono K; ten Dijke P; Kim S; Li E
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2626-31. PubMed ID: 10716993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor beta (TGFbeta ) signaling via differential activation of activin receptor-like kinases 2 and 5 during cardiac development. Role in regulating parasympathetic responsiveness.
    Ward SM; Desgrosellier JS; Zhuang X; Barnett JV; Galper JB
    J Biol Chem; 2002 Dec; 277(51):50183-9. PubMed ID: 12393881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A direct interaction between TGFbeta activated kinase 1 and the TGFbeta type II receptor: implications for TGFbeta signalling and cardiac hypertrophy.
    Watkins SJ; Jonker L; Arthur HM
    Cardiovasc Res; 2006 Feb; 69(2):432-9. PubMed ID: 16360132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for specificity of TGFβ family receptor small molecule inhibitors.
    Ogunjimi AA; Zeqiraj E; Ceccarelli DF; Sicheri F; Wrana JL; David L
    Cell Signal; 2012 Feb; 24(2):476-483. PubMed ID: 21983015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.